Search results
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 1 day agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...
Unknown risk factor linked to high rates of kidney cancer, DNA study finds
Medical Xpress· 3 days agoIn a paper published in Nature, scientists from the Mutographs Cancer Grand Challenges team, based at the Wellcome Sanger Institute, the International Agency for Research on Cancer, and a large ...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives $24.64 Average Target Price from Analysts
ETF DAILY NEWS· 6 days agoShares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are currently covering the stock, Marketbeat ...
Short Interest in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Rises By 5.6%
ETF DAILY NEWS· 4 days agoIovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares ...
Retirement Systems of Alabama Sells 8,056 Shares of Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 2 days agoRetirement Systems of Alabama cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure ...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 2 days agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
Headlands Technologies LLC Has $32,000 Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 2 days agoHeadlands Technologies LLC cut its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 70.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,341 shares of the biotechnology ...